Ultragenyx

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$18.29-$42.37
Market Cap
$2.3B
Shares Short
13M

Financials

See more
Revenue (12 Mos)
$670M
Revenue Growth (YoY)
-2.2%
Gross Profit (12 Mos)
-$188M
Diluted EPS
-$6.16

News

See more

Yahoo Finance • 8 days ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • last month

Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial

Yahoo Finance • 2 months ago

ULTRAGENYX URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ:RARE) Investors of the April 6th Lead Plaintiff Deadline and Urges Investors to Contact the Firm

Yahoo Finance • 2 months ago

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

About

CEO
Dr. Emil D. Kakkis M.D., Ph.D.
CFO
Mr. Howard Horn
Address
60 Leveroni Court, Novato, CA, United States, 94949
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,371